| Aranesp |
103951 |
034 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
40MCG/0.4ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
035 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
60MCG/0.3ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
036 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
100MCG/0.5ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
037 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
150MCG/0.3ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
038 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
200MCG/0.4ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
039 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
300MCG/0.6ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
040 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
500MCG/1ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
041 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
25MCG/0.42ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
042 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
40MCG/0.4ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
043 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
60MCG/0.3ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
044 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
100MCG/0.5ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
045 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
150MCG/0.3ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
046 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
200MCG/0.4ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
047 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
300MCG/0.6ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
048 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
500MCG/1ML |
Autoinjector |
2006/06/29
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Gardasil |
125126 |
001 |
351(a) |
Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant |
Injection |
Intramuscular |
120MCG L1 PROTEIN FROM HPV 6, 11, 16 AND 18 UG/.5ML |
Syringe |
2006/06/08
|
Merck Sharp & Dohme LLC |
Disc |
Licensed |
|
N/A |
| Omnitrope |
021426 |
001 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
5.8MG |
Multi-Dose Vial |
2006/05/30
|
Sandoz Inc. |
Rx |
Licensed |
N/A |
N/A |
| Omnitrope |
021426 |
002 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
1.5MG |
Single-Dose Vial |
2006/05/30
|
Sandoz Inc. |
Disc |
Licensed |
N/A |
N/A |
| Zostavax |
125123 |
001 |
351(a) |
Zoster Vaccine Live |
For Injection |
Subcutaneous |
0.65ML |
Single-Dose Vial |
2006/05/25
|
Merck Sharp & Dohme LLC |
Disc |
Licensed |
|
N/A |
| Myozyme |
125141 |
001 |
351(a) |
alglucosidase alfa |
For Injection |
Intravenous |
50MG |
Single-Dose Vial |
2006/04/28
|
Genzyme Corporation |
Disc |
Voluntarily Revoked |
N/A |
N/A |